Lynton and DEKA Celebrate the UK Launch of RedTouch PRO at Tower Bridge

On November 27, Lynton introduced RedTouch PRO to the UK aesthetic community with a landmark launch event at London’s Tower Bridge. Over 90 practitioners, clinic owners and industry leaders gathered for an exclusive look at the first laser to directly target collagen, marking a significant moment for the rapidly expanding collagen banking and regenerative skin health sector.
 
Hosted by Lynton CEO Dr Jon Exley and DEKA CEO Paolo Salvadeo, the evening brought together leading early adopters, including Dr Marwa Ali, Dr Ariel Haus and Dr Aggie Zatonska. Each shared their clinical perspective on how RedTouch PRO is shaping the next wave of pre-rejuvenation, as patient demand accelerates for non-ablative, biostimulating technologies that prioritise long-term dermal resilience.
 
Guests were given the opportunity to see the device and have meet-the-expert discussions, with the Lynton team on hand to guide one-to-one conversations around clinical protocols, treatment positioning and commercial integration. Attendees also entered a draw to win a place on an educational visit to DEKA’s headquarters in Florence, reinforcing the event’s focus on clinical excellence and global partnership.

The launch underscored RedTouch PRO’s position as a category-first technology. Operating at a proprietary 675 nm wavelength, it directly stimulates collagen types I, III and IV without ablating or traumatising the skin. This selective photobiomodulation effect supports improvements in firmness, smoothness and tone, aligning with the industry-wide shift towards science-led rejuvenation and minimally invasive treatment journeys.
 
Dr Jon Exley, managing director of Lynton, commented: “Launching RedTouch PRO at Tower Bridge allowed us to bring the industry together around a genuine step change in collagen-targeting technology. 

The response from practitioners and clinic leaders confirmed the scale of opportunity this platform presents, both clinically and commercially, as demand grows for precise, non-ablative rejuvenation.

Our partnership with DEKA continues to drive innovation in this space, and the phased rollout now underway will focus on giving clinics the training, education and integration support needed to maximise success. We look forward to building on this momentum as we prepare for the wider consumer campaign in 2026.”
 
The Tower Bridge event marks the beginning of Lynton and DEKA’s phased rollout for RedTouch PRO. With consumer-facing activity planned for early 2026, the focus now moves to supporting clinics nationwide with training, education and integration of this next-generation platform.